| 1 |
Shao T, Hsu R, Hacein-Bey C, Zhang W, Gao L, Kurth MJ, Zhao H, Shuai Z, Leung PSC. The Evolving Landscape of Fecal Microbial Transplantation. Clin Rev Allergy Immunol 2023;:1-20. [PMID: 36757537 DOI: 10.1007/s12016-023-08958-0] [Reference Citation Analysis]
|
| 2 |
Zheng M, Zhou W, Huang C, Hu Z, Zhang B, Lu Q, Zhao M. A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus. J Autoimmun 2023;135:102989. [PMID: 36610264 DOI: 10.1016/j.jaut.2022.102989] [Reference Citation Analysis]
|
| 3 |
Frostegård J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med 2023;293:48-62. [PMID: 35982610 DOI: 10.1111/joim.13557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Drakopanagiotakis F, Stavropoulou E, Tsigalou C, Nena E, Steiropoulos P. The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis. Biomedicines 2022;10. [PMID: 36551951 DOI: 10.3390/biomedicines10123195] [Reference Citation Analysis]
|
| 5 |
Li BZ, Wang H, Li XB, Zhang QR, Huang RG, Wu H, Wang YY, Li KD, Chu XJ, Cao NW, Zhou HY, Fang XY, Leng RX, Fan YG, Tao JH, Shuai ZW, Ye DQ. Altered gut fungi in systemic lupus erythematosus - A pilot study. Front Microbiol 2022;13:1031079. [PMID: 36545195 DOI: 10.3389/fmicb.2022.1031079] [Reference Citation Analysis]
|
| 6 |
Abril AG, Villa TG, Sánchez-Pérez Á, Notario V, Carrera M. The Role of the Gallbladder, the Intestinal Barrier and the Gut Microbiota in the Development of Food Allergies and Other Disorders. Int J Mol Sci 2022;23. [PMID: 36430811 DOI: 10.3390/ijms232214333] [Reference Citation Analysis]
|
| 7 |
Xin X, Wang Q, Qing J, Song W, Gui Y, Li X, Li Y. Th17 cells in primary Sjögren’s syndrome negatively correlate with increased Roseburia and Coprococcus. Front Immunol 2022;13:974648. [DOI: 10.3389/fimmu.2022.974648] [Reference Citation Analysis]
|
| 8 |
Yaigoub H, Fath N, Tirichen H, Wu C, Li R, Li Y. Bidirectional crosstalk between dysbiotic gut microbiota and systemic lupus erythematosus: What is new in therapeutic approaches? Clin Immunol 2022;244:109109. [PMID: 36087683 DOI: 10.1016/j.clim.2022.109109] [Reference Citation Analysis]
|
| 9 |
Topi S, Bottalico L, Charitos IA, Colella M, Di Domenico M, Palmirotta R, Santacroce L. Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe? Pathophysiology 2022;29:507-36. [DOI: 10.3390/pathophysiology29030041] [Reference Citation Analysis]
|
| 10 |
Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmun Rev 2022;21:103169. [PMID: 35964945 DOI: 10.1016/j.autrev.2022.103169] [Reference Citation Analysis]
|
| 11 |
Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Matsuda S. Roles of Reactive Oxygen Species and Autophagy in the Pathogenesis of Cisplatin-Induced Acute Kidney Injury. Oxygen 2022;2:317-326. [DOI: 10.3390/oxygen2030022] [Reference Citation Analysis]
|
| 12 |
Chen Y, Lin J, Xiao L, Zhang X, Zhao L, Wang M, Li L. Gut microbiota in systemic lupus erythematosus: A fuse and a solution. J Autoimmun 2022;132:102867. [PMID: 35932662 DOI: 10.1016/j.jaut.2022.102867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Charoensappakit A, Sae-Khow K, Leelahavanichkul A. Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease. Int J Mol Sci 2022;23:8223. [PMID: 35897790 DOI: 10.3390/ijms23158223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Sun X, Chen J, Huang Y, Zhu S, Wang S, Xu Z, Zhang J, Sun W. Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity. Front Pharmacol 2022;13:858881. [DOI: 10.3389/fphar.2022.858881] [Reference Citation Analysis]
|
| 15 |
Tsigalou C, Konstantinidis T, Aloizou A, Bezirtzoglou E, Tsakris A. Future Therapeutic Prospects in Dealing with Autoimmune Diseases: Treatment Based on the Microbiome Model. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_25] [Reference Citation Analysis]
|
| 16 |
Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Matsuda S. Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma. Explor Target Antitumor Ther 2022;3:817-27. [PMID: 36654824 DOI: 10.37349/etat.2022.00114] [Reference Citation Analysis]
|
